Connection

ANTONE OPEKUN to Male

This is a "connection" page, showing publications ANTONE OPEKUN has written about Male.
Connection Strength

0.354
  1. Clinical Performance of the Automated LIAISON? Meridian H. pylori SA Stool Antigen Test. Biomed Res Int. 2020; 2020:7189519.
    View in: PubMed
    Score: 0.029
  2. Brief report: Lactobacillus bulgaricus GLB44 (Proviotic? ) plus esomeprazole for Helicobacter pylori eradication: A pilot study. Helicobacter. 2018 Apr; 23(2):e12476.
    View in: PubMed
    Score: 0.025
  3. Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders. Biomed Res Int. 2016; 2016:7952891.
    View in: PubMed
    Score: 0.023
  4. Dual proton pump inhibitor plus amoxicillin as an empiric anti-H. pylori therapy: studies from the United States. J Gastroenterol. 2010 Aug; 45(8):816-20.
    View in: PubMed
    Score: 0.014
  5. Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Aliment Pharmacol Ther. 2006 Sep 01; 24(5):845-50.
    View in: PubMed
    Score: 0.011
  6. Point-of-care Helicobacter pylori urine antibody detection in a multi-ethnic adult population in the United States. Transl Res. 2006 Jul; 148(1):13-8.
    View in: PubMed
    Score: 0.011
  7. Improved infrared spectrophotometer for point-of-care patient 13C-urea breath testing in the primary care setting. Clin Biochem. 2005 Aug; 38(8):731-4.
    View in: PubMed
    Score: 0.010
  8. In vivo tests of natural therapy, Tibetan yogurt or fresh broccoli, for Helicobacter pylori infection. Methods Find Exp Clin Pharmacol. 2005 Jun; 27(5):327-9.
    View in: PubMed
    Score: 0.010
  9. Practical rapid, minimally invasive, reliable nonendoscopic method to obtain Helicobacter pylori for culture. Helicobacter. 2005 Feb; 10(1):1-3.
    View in: PubMed
    Score: 0.010
  10. Genetic Variation Between Small Bowel and Colon-Predominant Crohn's Disease. Cell Mol Gastroenterol Hepatol. 2024; 17(6):1069-1071.
    View in: PubMed
    Score: 0.009
  11. Clinical Characterization of Pediatric Gastroparesis Using a Four-hour Gastric Emptying Scintigraphy Standard. J Pediatr Gastroenterol Nutr. 2021 06 01; 72(6):848-853.
    View in: PubMed
    Score: 0.008
  12. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020 10 27; 10(1):18341.
    View in: PubMed
    Score: 0.008
  13. Helicobacter pylori infection in children of Texas. J Pediatr Gastroenterol Nutr. 2000 Oct; 31(4):405-10.
    View in: PubMed
    Score: 0.008
  14. Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther. 1999 Jan; 13(1):35-42.
    View in: PubMed
    Score: 0.007
  15. Demographic and Clinical Correlates of Mucosal Disaccharidase Deficiencies in Children With Functional Dyspepsia. J Pediatr Gastroenterol Nutr. 2018 Jun; 66 Suppl 3:S52-S55.
    View in: PubMed
    Score: 0.006
  16. 13C-Labeled-Starch Breath Test in Congenital Sucrase-isomaltase Deficiency. J Pediatr Gastroenterol Nutr. 2018 Jun; 66 Suppl 3:S61-S64.
    View in: PubMed
    Score: 0.006
  17. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
    View in: PubMed
    Score: 0.006
  18. Traditional Malian Solid Foods Made from Sorghum and Millet Have Markedly Slower Gastric Emptying than Rice, Potato, or Pasta. Nutrients. 2018 Jan 26; 10(2).
    View in: PubMed
    Score: 0.006
  19. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47.
    View in: PubMed
    Score: 0.006
  20. Improved Starch Digestion of Sucrase-deficient Shrews Treated With Oral Glucoamylase Enzyme Supplements. J Pediatr Gastroenterol Nutr. 2017 08; 65(2):e35-e42.
    View in: PubMed
    Score: 0.006
  21. [13C]Aminopyrine breath test detects altered liver metabolism caused by low-dose oral contraceptives. Dig Dis Sci. 1995 Nov; 40(11):2417-22.
    View in: PubMed
    Score: 0.005
  22. Serological Correlates of Protection against a GII.4 Norovirus. Clin Vaccine Immunol. 2015 Aug; 22(8):923-9.
    View in: PubMed
    Score: 0.005
  23. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study. Crit Care Med. 1995 Apr; 23(4):687-91.
    View in: PubMed
    Score: 0.005
  24. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis. BMC Immunol. 2015 Feb 10; 16:5.
    View in: PubMed
    Score: 0.005
  25. Reply to Kirby et al. J Infect Dis. 2015 Jan 01; 211(1):167.
    View in: PubMed
    Score: 0.005
  26. DNA methylation-associated colonic mucosal immune and defense responses in treatment-na?ve pediatric ulcerative colitis. Epigenetics. 2014 Aug; 9(8):1131-7.
    View in: PubMed
    Score: 0.005
  27. Equivalence of litmus paper and intragastric pH probes for intragastric pH monitoring in the intensive care unit. Crit Care Med. 1994 Jun; 22(6):945-8.
    View in: PubMed
    Score: 0.005
  28. Randomized trial to evaluate nutritional status and absorption of enteral feeding after brain death. Prog Transplant. 2013 Dec; 23(4):374-82.
    View in: PubMed
    Score: 0.005
  29. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis. 2014 Apr 01; 209(7):1016-22.
    View in: PubMed
    Score: 0.005
  30. Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis. 2012 Dec; 18(12):2334-41.
    View in: PubMed
    Score: 0.004
  31. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011 Dec 08; 365(23):2178-87.
    View in: PubMed
    Score: 0.004
  32. Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol Nutr. 2010 Jan; 50(1):27-31.
    View in: PubMed
    Score: 0.004
  33. Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol. 2010 Jan; 8(1):36-41.e1.
    View in: PubMed
    Score: 0.004
  34. Urea breath test in children: the United States prospective, multicenter study. Helicobacter. 2009 Apr; 14(2):134-40.
    View in: PubMed
    Score: 0.003
  35. 13C-breath tests for sucrose digestion in congenital sucrase isomaltase-deficient and sacrosidase-supplemented patients. J Pediatr Gastroenterol Nutr. 2009 Apr; 48(4):412-8.
    View in: PubMed
    Score: 0.003
  36. Spicy food and the stomach. Evaluation by videoendoscopy. JAMA. 1988 Dec 16; 260(23):3473-5.
    View in: PubMed
    Score: 0.003
  37. Visualization of the small intestine using capsule endoscopy in healthy subjects. Dig Dis Sci. 2007 Apr; 52(4):1019-25.
    View in: PubMed
    Score: 0.003
  38. Two familial cases of high blood galactose of unknown aetiology. J Inherit Metab Dis. 2006 Dec; 29(6):762.
    View in: PubMed
    Score: 0.003
  39. Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections. Helicobacter. 2006 Apr; 11(2):69-74.
    View in: PubMed
    Score: 0.003
  40. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol. 2006 Mar; 4(3):306-14.
    View in: PubMed
    Score: 0.003
  41. Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border. Aliment Pharmacol Ther. 2006 Jan 15; 23(2):295-301.
    View in: PubMed
    Score: 0.003
  42. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun. 2005 May; 73(5):2999-3006.
    View in: PubMed
    Score: 0.003
  43. Effect of different organic acids (citric, malic and ascorbic) on intragastric urease activity. Aliment Pharmacol Ther. 2005 May 01; 21(9):1145-8.
    View in: PubMed
    Score: 0.003
  44. Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Helicobacter. 2005 Apr; 10(2):136-8.
    View in: PubMed
    Score: 0.003
  45. Novel bismuth-metronidazole-tetracycline triple-layer tablet for treatment of Helicobacter pylori. Aliment Pharmacol Ther. 2005 Jan 15; 21(2):165-8.
    View in: PubMed
    Score: 0.003
  46. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005 Jan; 3(1):55-9.
    View in: PubMed
    Score: 0.003
  47. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004 Sep; 53(9):1235-43.
    View in: PubMed
    Score: 0.002
  48. Migrating shell fragment as a cause of recurrent obscure gastrointestinal bleeding. J Clin Gastroenterol. 2004 Feb; 38(2):137-8.
    View in: PubMed
    Score: 0.002
  49. False negative urea breath tests with H2-receptor antagonists: interactions between Helicobacter pylori density and pH. Helicobacter. 2004 Feb; 9(1):17-27.
    View in: PubMed
    Score: 0.002
  50. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol. 2003 May; 98(5):1005-9.
    View in: PubMed
    Score: 0.002
  51. Endoscopic demonstration of transient small bowel intussusception in a patient with adult celiac disease. Gastrointest Endosc. 2003 Apr; 57(4):626-7.
    View in: PubMed
    Score: 0.002
  52. Early events in proton pump inhibitor-associated exacerbation of corpus gastritis. Aliment Pharmacol Ther. 2003 Jan; 17(2):193-200.
    View in: PubMed
    Score: 0.002
  53. Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res. 2002 Aug; 43(8):1170-80.
    View in: PubMed
    Score: 0.002
  54. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr. 2000 Aug; 31(2):136-41.
    View in: PubMed
    Score: 0.002
  55. Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study. Aliment Pharmacol Ther. 2000 Jun; 14(6):745-50.
    View in: PubMed
    Score: 0.002
  56. Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment Pharmacol Ther. 2000 Feb; 14(2):211-5.
    View in: PubMed
    Score: 0.002
  57. Evidence of SV40 infections in hospitalized children. Hum Pathol. 1999 Dec; 30(12):1496-502.
    View in: PubMed
    Score: 0.002
  58. Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology. 1999 Jul; 117(1):40-8.
    View in: PubMed
    Score: 0.002
  59. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis. 1994 Jul; 170(1):34-43.
    View in: PubMed
    Score: 0.001
  60. Effect of dietary cholesterol on cholesterol synthesis in breast-fed and formula-fed infants. J Lipid Res. 1993 Aug; 34(8):1403-11.
    View in: PubMed
    Score: 0.001
  61. Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuth subsalicylate and nitrofurantoin. Am J Gastroenterol. 1991 Sep; 86(9):1158-62.
    View in: PubMed
    Score: 0.001
  62. Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet. 1991 Jun 22; 337(8756):1503-6.
    View in: PubMed
    Score: 0.001
  63. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology. 1991 Jun; 100(6):1571-5.
    View in: PubMed
    Score: 0.001
  64. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol. 1990 Apr; 85(4):394-8.
    View in: PubMed
    Score: 0.001
  65. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology. 1989 Mar; 96(3):683-9.
    View in: PubMed
    Score: 0.001
  66. Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to heterologous serotypes. FEMS Microbiol Immunol. 1988 Dec; 1(3):117-25.
    View in: PubMed
    Score: 0.001
  67. Immunoprotective oral whole cell vaccine for enterotoxigenic Escherichia coli diarrhea prepared by in situ destruction of chromosomal and plasmid DNA with colicin E2. FEMS Microbiol Immunol. 1988 Jan; 1(1):9-18.
    View in: PubMed
    Score: 0.001
  68. Epidemiology of Campylobacter pylori infection: ethnic considerations. Scand J Gastroenterol Suppl. 1988; 142:9-13.
    View in: PubMed
    Score: 0.001
  69. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet. 1987 May 23; 1(8543):1174-7.
    View in: PubMed
    Score: 0.001
  70. Controlled comparison of topical anesthetic agents in flexible upper gastrointestinal endoscopy. Gastrointest Endosc. 1985 Aug; 31(4):255-8.
    View in: PubMed
    Score: 0.001
  71. Ranitidine and hepatotoxicity. Ann Intern Med. 1985 Mar; 102(3):416.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.